Citation Tools
PDFReview
Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?
Other content recommended for you
- CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer’s disease: a meta-analysis of 51 studies
- Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis
- Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease
- New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist
- CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
- Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study
- Use of laboratory and imaging investigations in dementia
- Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
- Mild cognitive impairment in primary care: a clinical review
- Clinical trials in mild cognitive impairment: lessons for the future